IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ASMB

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents32.2931.1258.4522.5324.0123.4138.3428.4519.2118.7519.8426.6621.6243.4852.4254.6743.0651.1745.6370.76
Accounts Receivable0.820.450.970.91----0.000.000.000.040.040.000.340.720.941.250.520.520.340.77
Total Current Assets327.98232.61254.55236.8177.4795.53115.5098.21112.93117.17133.7949.6764.0879.7496.97115.08124.29130.78154.20188.22
Property, Plant & Equipment0.320.210.220.230.220.250.280.320.350.370.390.560.540.620.740.870.901.021.141.24
Goodwill--------------------------------------12.64
Total Non-current Assets*2.852.903.043.193.313.493.672.052.392.723.041.962.503.374.836.4419.1531.9536.8660.75
Total Assets330.83235.51257.59240.0080.7899.02119.17100.26115.32119.88136.8251.6366.5883.12101.79121.52143.45162.73191.06248.97
Accounts Payable1.181.131.171.680.740.880.591.340.800.730.460.760.901.222.491.942.451.412.662.63
Total Current Liabilities23.4535.0048.7853.3847.2946.6347.8041.6441.2738.7539.237.138.839.9716.3015.4614.9610.7116.0714.93
Total Non-current Liabilities*1.741.902.063.9215.3925.2538.0132.6239.3748.5356.502.782.802.812.833.654.515.236.069.40
Total Liabilities25.1836.9050.8457.3062.6871.8885.8174.2680.6487.2895.739.9111.6312.7819.1319.1119.4715.9422.1324.33
Retained Earnings(844.98)(841.13)(832.05)(854.14)(844.94)(834.74)(825.92)(815.59)(805.98)(794.82)(785.75)(774.79)(760.37)(743.47)(724.52)(702.12)(678.98)(654.52)(631.43)(571.17)
Total Stockholder Equity305.65198.61206.75182.7018.1027.1333.3626.0034.6832.6041.1041.7154.9570.3382.66102.40123.98146.79168.93224.65
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue13.378.2142.4710.799.639.427.366.858.535.797.160.000.000.00--------0.006.25
Research & Development14.9214.9017.2516.5916.1314.8514.2813.5216.2611.8811.0110.8212.5214.5516.8518.1317.7917.2014.7518.47
Selling, General & Admin4.804.685.425.094.594.514.614.294.484.648.714.224.975.016.135.276.785.966.506.66
Total Operating Expenses19.7219.5822.6721.6720.7219.3618.8917.8020.7416.5119.7115.0517.4919.5622.9823.4024.5723.1662.8925.13
Operating Income(6.34)(11.37)19.80(10.88)(11.09)(9.94)(11.53)(10.96)(12.20)(10.73)(12.55)(15.05)(17.49)(19.56)(22.98)(23.40)(24.57)(23.16)(62.89)(18.87)
Pretax Income----22.09(9.20)(10.20)--(10.41)(9.61)(10.75)----------------------
Tax Provision----0.000.000.00--(0.08)0.000.41----------------------
Net Income(3.86)(9.08)22.09(9.20)(10.20)(8.82)(10.33)(9.61)(11.15)(9.08)(10.96)(14.42)(16.90)(18.95)(22.39)(23.14)(24.46)(23.09)(60.26)(18.80)
Basic EPS(0.20)(0.54)2.67(0.72)(1.33)(1.17)(1.54)(1.51)(1.98)(1.66)(12.42)(0.27)(0.32)(0.37)(0.46)(0.48)(0.51)------
Diluted EPS(0.20)(0.54)2.67(0.72)(1.33)(1.17)(1.54)(1.51)(1.98)(1.66)(12.42)(0.27)(0.32)(0.37)(0.46)(0.48)(0.51)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(15.49)(22.10)14.24(15.13)(16.76)(23.44)(0.41)(15.24)(17.10)(18.36)73.65(13.85)(13.63)(23.43)(19.25)(19.82)(17.89)(27.50)(19.36)(18.88)
Capital Expenditures0.000.020.020.040.000.000.000.000.010.010.070.140.05--0.000.100.000.000.020.00
Free Cash Flow*(15.49)(22.12)14.21(15.17)(16.76)(23.44)(0.41)(15.24)(17.12)(18.38)73.58(13.98)(13.68)--(19.25)(19.92)(17.89)(27.50)(19.38)(18.88)
Investing Cash Flow(92.08)(5.38)21.22(158.27)16.996.59(6.70)24.495.1117.27(89.65)18.88(8.36)10.0016.5631.439.6033.05(8.48)20.07
Financing Cash Flow108.740.150.46171.930.361.9217.000.0012.450.009.190.000.134.490.440.000.180.002.7110.06
← Scroll for more columns →

* Derived from reported values